BNP Paribas Financial Markets’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $108M | Buy |
571,987
+404,675
| +242% | +$76.1M | 0.04% | 420 |
|
|
2026
Q1 | $33M | Sell |
167,312
-324,891
| -66% | -$62.6M | 0.02% | 876 |
|
|
2025
Q4 | $90.5M | Sell |
492,203
-318,949
| -39% | -$55.9M | 0.04% | 440 |
|
|
2025
Q3 | $124M | Buy |
811,152
+532,103
| +191% | +$80.5M | 0.07% | 298 |
|
|
2025
Q2 | $39M | Buy |
279,049
+48,653
| +21% | +$6.82M | 0.02% | 694 |
|
|
2025
Q1 | $33.9M | Sell |
230,396
-2,962
| -1% | -$429K | 0.02% | 785 |
|
|
2024
Q4 | $30.6M | Sell |
233,358
-24,635
| -10% | -$3.45M | 0.02% | 837 |
|
|
2024
Q3 | $40.2M | Sell |
257,993
-27,410
| -10% | -$4.42M | 0.03% | 581 |
|
|
2024
Q2 | $44.5M | Buy |
285,403
+58,692
| +26% | +$8.83M | 0.04% | 454 |
|
|
2024
Q1 | $30.7M | Sell |
226,711
-21,064
| -9% | -$2.79M | 0.03% | 581 |
|
|
2023
Q4 | $33.4M | Buy |
247,775
+185,429
| +297% | +$24.1M | 0.04% | 498 |
|
|
2023
Q3 | $8.44M | Sell |
62,346
-56,700
| -48% | -$7.74M | 0.01% | 984 |
|
|
2023
Q2 | $17M | Sell |
119,046
-54,874
| -32% | -$8.07M | 0.02% | 691 |
|
|
2023
Q1 | $24.1M | Buy |
173,920
+73,200
| +73% | +$9.85M | 0.03% | 515 |
|
|
2022
Q4 | $13.7M | Sell |
100,720
-62,930
| -38% | -$7.89M | 0.02% | 821 |
|
|
2022
Q3 | $17.9M | Buy |
163,650
+105,184
| +180% | +$13.3M | 0.03% | 682 |
|
|
2022
Q2 | $7.73M | Buy |
58,466
+32,567
| +126% | +$4.27M | 0.01% | 1031 |
|
|
2022
Q1 | $3.44M | Buy |
25,899
+17,780
| +219% | +$2.13M | ﹤0.01% | 1486 |
|
|
2021
Q4 | $946K | Sell |
8,119
-142,915
| -95% | -$16.8M | ﹤0.01% | 2633 |
|
|
2021
Q3 | $18.1M | Buy |
151,034
+147,088
| +3,728% | +$17.1M | 0.03% | 649 |
|
|
2021
Q2 | $473K | Sell |
3,946
-3,488
| -47% | -$383K | ﹤0.01% | 2559 |
|
|
2021
Q1 | $739K | Sell |
7,434
-1,407
| -16% | -$141K | ﹤0.01% | 2329 |
|
|
2020
Q4 | $884K | Buy |
8,841
+2,894
| +49% | +$307K | ﹤0.01% | 2102 |
|
|
2020
Q3 | $652K | Buy |
5,947
+2,518
| +73% | +$280K | ﹤0.01% | 2052 |
|
|
2020
Q2 | $363K | Buy |
3,429
+2,408
| +236% | +$249K | ﹤0.01% | 2231 |
|
|
2020
Q1 | $91.2K | Buy |
1,021
+441
| +76% | +$41.5K | ﹤0.01% | 3255 |
|
|
2019
Q4 | $57.8K | Sell |
580
-6,214
| -91% | -$585K | ﹤0.01% | 3566 |
|
|
2019
Q3 | $606K | Buy |
6,794
+5,870
| +635% | +$509K | ﹤0.01% | 2101 |
|
|
2019
Q2 | $76.3K | Sell |
924
-88
| -9% | -$6.9K | ﹤0.01% | 3190 |
|
|
2019
Q1 | $81.8K | Buy |
1,012
+29
| +3% | +$2.29K | ﹤0.01% | 3242 |
|
|
2018
Q4 | $74.7K | Sell |
983
-1,041
| -51% | -$81.3K | ﹤0.01% | 2509 |
|
|
2018
Q3 | $160K | Buy |
2,024
+26
| +1% | +$1.97K | ﹤0.01% | 2498 |
|
|
2018
Q2 | $140K | Buy |
1,998
+234
| +13% | +$16.8K | ﹤0.01% | 2614 |
|
|
2018
Q1 | $123K | Sell |
1,764
-3,716
| -68% | -$257K | ﹤0.01% | 3086 |
|
|
2017
Q4 | $380K | Buy |
5,480
+1,131
| +26% | +$76.3K | ﹤0.01% | 2631 |
|
|
2017
Q3 | $295K | Sell |
4,349
-78,471
| -95% | -$4.96M | ﹤0.01% | 2261 |
|
|
2017
Q2 | $5.65M | Buy |
82,820
+54,008
| +187% | +$3.53M | 0.02% | 720 |
|
|
2017
Q1 | $1.79M | Sell |
28,812
-14,333
| -33% | -$834K | ﹤0.01% | 1107 |
|
|
2016
Q4 | $2.36M | Buy |
43,145
+34,942
| +426% | +$1.98M | 0.01% | 883 |
|
|
2016
Q3 | $539K | Sell |
8,203
-11,226
| -58% | -$734K | ﹤0.01% | 1181 |
|
|
2016
Q2 | $1.17M | Buy |
19,429
+16,508
| +565% | +$959K | 0.01% | 1105 |
|
|
2016
Q1 | $164K | Sell |
2,921
-184,061
| -98% | -$11.1M | ﹤0.01% | 1613 |
|
|
2015
Q4 | $12.7M | Buy |
186,982
+93,423
| +100% | +$6.13M | 0.03% | 400 |
|
|
2015
Q3 | $5.95M | Sell |
93,559
-8,354
| -8% | -$550K | 0.01% | 585 |
|
|
2015
Q2 | $6.49M | Buy |
101,913
+8,984
| +10% | +$615K | 0.02% | 513 |
|
|
2015
Q1 | $6.36M | Hold |
92,929
| – | – | 0.02% | 547 |
|
|
2014
Q4 | $6.54M | Buy |
92,929
+14,414
| +18% | +$1.03M | 0.02% | 561 |
|
|
2014
Q3 | $5.61M | Buy |
78,515
+9,465
| +14% | +$693K | ﹤0.01% | 690 |
|
|
2014
Q2 | $5.13M | Buy |
69,050
+3,764
| +6% | +$272K | ﹤0.01% | 657 |
|
|
2014
Q1 | $5.16M | Buy |
65,286
+60,880
| +1,382% | +$3.93M | ﹤0.01% | 647 |
|
|
2013
Q4 | $262K | Sell |
4,406
-17,156
| -80% | -$932K | ﹤0.01% | 1446 |
|
|
2013
Q3 | $1.12M | Buy |
21,562
+12,260
| +132% | +$616K | ﹤0.01% | 1098 |
|
|
2013
Q2 | $440K | Buy |
+9,302
| New | +$474K | ﹤0.01% | 1662 |
|
Other funds holding AZN
EPGL
VCM
VAM
VFT
BNP Paribas Financial Markets's AZN Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its AstraZeneca (AZN) stake by 242% in Q2 2026, buying an estimated $76.1M and bringing the position to 571,987 shares worth $108M. The position accounts for 0.04% of the portfolio, ranked #420.
BNP Paribas Financial Markets first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $124M in Q3 2025. 1,259 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- BNP Paribas Financial Markets held 571,987 shares of AstraZeneca worth $108M as of Q2 2026.
- BNP Paribas Financial Markets bought 404,675 AstraZeneca shares in Q2 2026, an estimated $76.1M.
- AstraZeneca made up 0.04% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #420 holding.
- BNP Paribas Financial Markets first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's AstraZeneca position peaked at $124M in Q3 2025.
- 1,259 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.